S. M. Jamshedur Rahman, Ph.D.

Research Assistant Professor

j.rahman@vanderbilt.edu
Faculty Appointments
Research Assistant Professor of Medicine
Education
Ph.D., Immunology, Nagoya University, Nagoya, JapanM.Sc., Biochemistry, University of Dhaka, Dhaka, BangladeshB.Sc., University of Dhaka, Dhaka, Bangladesh
Office Address
PRB 642B
TN 6838
Research Description
Proteomic and genomic analysis of normal bronchial epithelium and preinvasive bronchial lesion from individuals at risk of lung cancer. The goal is to develop signature for the early diagnosis of lung cancer.

Role of acyl-coA binding protein in lung tumorigenesis
Research Keywords
Proteomic and genomic biomarker signatures for the early diagnosis of lung cancer
Publications
Qian J, Hassanein M, Hoeksema MD, Harris BK, Zou Y, Chen H, Lu P, Eisenberg R, Wang J, Espinosa A, Ji X, Harris FT, Rahman SM, Massion PP. The RNA binding protein FXR1 is a new driver in the 3q26-29 amplicon and predicts poor prognosis in human cancers. Proc. Natl. Acad. Sci. U.S.A [print-electronic]. 2015 Mar 3/17/2015; 112(11): 3469-74. PMID: 25733852, PMCID: PMC4371932, PII: 1421975112, DOI: 10.1073/pnas.1421975112, ISSN: 1091-6490.

Harris FT, Rahman SM, Hassanein M, Qian J, Hoeksema MD, Chen H, Eisenberg R, Chaurand P, Caprioli RM, Shiota M, Massion PP. Acyl-coenzyme A-binding protein regulates Beta-oxidation required for growth and survival of non-small cell lung cancer. Cancer Prev Res (Phila) [print-electronic]. 2014 Jul; 7(7): 748-57. PMID: 24819876, PMCID: PMC4090029, PII: 1940-6207.CAPR-14-0057, DOI: 10.1158/1940-6207.CAPR-14-0057, ISSN: 1940-6215.

Wang J, Qian J, Hoeksema MD, Zou Y, Espinosa AV, Rahman SM, Zhang B, Massion PP. Integrative genomics analysis identifies candidate drivers at 3q26-29 amplicon in squamous cell carcinoma of the lung. Clin. Cancer Res [print-electronic]. 2013 Oct 10/15/2013; 19(20): 5580-90. PMID: 23908357, PMCID: PMC3807802, PII: 1078-0432.CCR-13-0594, DOI: 10.1158/1078-0432.CCR-13-0594, ISSN: 1078-0432.

Kikuchi T, Hassanein M, Amann JM, Liu Q, Slebos RJ, Rahman SM, Kaufman JM, Zhang X, Hoeksema MD, Harris BK, Li M, Shyr Y, Gonzalez AL, Zimmerman LJ, Liebler DC, Massion PP, Carbone DP. In-depth proteomic analysis of nonsmall cell lung cancer to discover molecular targets and candidate biomarkers. Mol. Cell Proteomics [print-electronic]. 2012 Oct; 11(10): 916-32. PMID: 22761400, PMCID: PMC3494148, PII: M111.015370, DOI: 10.1074/mcp.M111.015370, ISSN: 1535-9484.

Zhang H, Liu Q, Zimmerman LJ, Ham AJ, Slebos RJ, Rahman J, Kikuchi T, Massion PP, Carbone DP, Billheimer D, Liebler DC. Methods for peptide and protein quantitation by liquid chromatography-multiple reaction monitoring mass spectrometry. Mol. Cell Proteomics [print-electronic]. 2011 Jun; 10(6): M110.006593. PMID: 21357624, PMCID: PMC3108838, PII: M110.006593, DOI: 10.1074/mcp.M110.006593, ISSN: 1535-9484.

Hassanein M, Rahman JS, Chaurand P, Massion PP. Advances in proteomic strategies toward the early detection of lung cancer. Proc Am Thorac Soc. 2011 May; 8(2): 183-8. PMID: 21543799, PMCID: PMC3131837, PII: 8/2/183, DOI: 10.1513/pats.201012-069MS, ISSN: 1943-5665.

Rahman SM, Gonzalez AL, Li M, Seeley EH, Zimmerman LJ, Zhang XJ, Manier ML, Olson SJ, Shah RN, Miller AN, Putnam JB, Miller YE, Franklin WA, Blot WJ, Carbone DP, Shyr Y, Caprioli RM, Massion PP. Lung cancer diagnosis from proteomic analysis of preinvasive lesions. Cancer Res [print-electronic]. 2011 Apr 4/15/2011; 71(8): 3009-17. PMID: 21487035, PMCID: PMC3110721, PII: 0008-5472.CAN-10-2510, DOI: 10.1158/0008-5472.CAN-10-2510, ISSN: 1538-7445.

Qian J, Zou Y, Rahman JS, Lu B, Massion PP. Synergy between phosphatidylinositol 3-kinase/Akt pathway and Bcl-xL in the control of apoptosis in adenocarcinoma cells of the lung. Mol. Cancer Ther. 2009 Jan; 8(1): 101-9. PMID: 19139118, PMCID: PMC3110728, PII: 8/1/101, DOI: 10.1158/1535-7163.MCT-08-0973, ISSN: 1535-7163.

Yildiz PB, Shyr Y, Rahman JS, Wardwell NR, Zimmerman LJ, Shakhtour B, Gray WH, Chen S, Li M, Roder H, Liebler DC, Bigbee WL, Siegfried JM, Weissfeld JL, Gonzalez AL, Ninan M, Johnson DH, Carbone DP, Caprioli RM, Massion PP. Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer. J Thorac Oncol. 2007 Oct; 2(10): 893-901. PMID: 17909350, PMCID: PMC4220686, PII: 01243894-200710000-00004, DOI: 10.1097/JTO.0b013e31814b8be7, ISSN: 1556-1380.

Rahman SM, Shyr Y, Yildiz PB, Gonzalez AL, Li H, Zhang X, Chaurand P, Yanagisawa K, Slovis BS, Miller RF, Ninan M, Miller YE, Franklin WA, Caprioli RM, Carbone DP, Massion PP. Proteomic patterns of preinvasive bronchial lesions. Am. J. Respir. Crit. Care Med [print-electronic]. 2005 Dec 12/15/2005; 172(12): 1556-62. PMID: 16179643, PMCID: PMC2718455, PII: 200502-274OC, DOI: 10.1164/rccm.200502-274OC, ISSN: 1073-449X.

Massion PP, Taflan PM, Shyr Y, Rahman SM, Yildiz P, Shakthour B, Edgerton ME, Ninan M, Andersen JJ, Gonzalez AL. Early involvement of the phosphatidylinositol 3-kinase/Akt pathway in lung cancer progression. Am. J. Respir. Crit. Care Med [print-electronic]. 2004 Nov 11/15/2004; 170(10): 1088-94. PMID: 15317667, PII: 200404-487OC, DOI: 10.1164/rccm.200404-487OC, ISSN: 1073-449X.

Massion PP, Taflan PM, Rahman SM, Yildiz P, Shyr Y, Carbone DP, Gonzalez AL. Role of p63 amplification and overexpression in lung cancer development. Chest. 2004 May; 125(5 Suppl): 102S. PMID: 15136437, ISSN: 0012-3692.

Massion PP, Taflan PM, Jamshedur Rahman SM, Yildiz P, Shyr Y, Edgerton ME, Westfall MD, Roberts JR, Pietenpol JA, Carbone DP, Gonzalez AL. Significance of p63 amplification and overexpression in lung cancer development and prognosis. Cancer Res. 2003 Nov 11/1/2003; 63(21): 7113-21. PMID: 14612504, ISSN: 0008-5472.

Petro JB, Rahman SM, Ballard DW, Khan WN. Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement. J. Exp. Med. 2000 May 5/15/2000; 191(10): 1745-54. PMID: 10811867, PMCID: PMC2193161, ISSN: 0022-1007.

Resta R, Hooker SW, Laurent AB, Jamshedur Rahman SM, Franklin M, Knudsen TB, Nadon NL, Thompson LF. Insights into thymic purine metabolism and adenosine deaminase deficiency revealed by transgenic mice overexpressing ecto-5'-nucleotidase (CD73). J. Clin. Invest. 1997 Feb 2/15/1997; 99(4): 676-83. PMID: 9045870, PMCID: PMC507850, DOI: 10.1172/JCI119211, ISSN: 0021-9738.

Rahman SM, Pu MY, Yi H, Ohkusu K, Kato M, Isobe K, Taguchi R, Ikezawa H, Nakashima I. Promotion of cytotoxic T-cell generation in mixed leukocyte culture by phosphatidylinositol-specific phospholipase C from Bacillus thuringiensis. Infect. Immun. 1995 Jan; 63(1): 259-63. PMID: 7806363, PMCID: PMC172986, ISSN: 0019-9567.

Nakashima I, Pu MY, Nishizaki A, Rosila I, Ma L, Katano Y, Ohkusu K, Rahman SM, Isobe K, Hamaguchi M. Redox mechanism as alternative to ligand binding for receptor activation delivering disregulated cellular signals. J. Immunol. 1994 Feb 2/1/1994; 152(3): 1064-71. PMID: 7507957, ISSN: 0022-1767.

Nakashima I, Pu MY, Hamaguchi M, Iwamoto T, Rahman SM, Zhang YH, Kato M, Ohkusu K, Katano Y, Yoshida T. Pathway of signal delivery to murine thymocytes triggered by co-crosslinking CD3 and Thy-1 for cellular DNA fragmentation and growth inhibition. J. Immunol. 1993 Oct 10/1/1993; 151(7): 3511-20. PMID: 8104221, ISSN: 0022-1767.

Rahman SM, Pu MY, Hamaguchi M, Iwamoto T, Isobe K, Nakashima I. Redox-linked ligand-independent cell surface triggering for extensive protein tyrosine phosphorylation. FEBS Lett. 1993 Feb 2/8/1993; 317(1-2): 35-8. PMID: 8381367, PII: 001457939381486J, ISSN: 0014-5793.

Jamshedur Rahman SM, Pu MV, Zhang YH, Hamaguchi M, Iwamoto T, Taguchi R, Ikezawa H, Isobe K, Yoshida T, Nakashima I. Delivery of an accessory signal for cell activation by exogenous phosphatidylinositol-specific phospholipase C. FEBS Lett. 1992 Jun 6/1/1992; 303(2-3): 193-6. PMID: 1535048, ISSN: 0014-5793.

Nakashima I, Zhang YH, Rahman SM, Yoshida T, Isobe K, Ding LN, Iwamoto T, Hamaguchi M, Ikezawa H, Taguchi R. Evidence of synergy between Thy-1 and CD3/TCR complex in signal delivery to murine thymocytes for cell death. J. Immunol. 1991 Aug 8/15/1991; 147(4): 1153-62. PMID: 1678398, ISSN: 0022-1767.

Nakamura M, Yoshida T, Isobe K, Iwamoto T, Jamshedur Rahman SM, Zhang YH, Hasegawa T, Ichihara M, Nakashima I. Modulation of the secondary antibody response of murine lymphocytes to sheep red blood cells in vitro by neuraminidase and exoglycosidases. Immunol. Lett. 1991 Aug; 29(3): 235-40. PMID: 1685149, ISSN: 0165-2478.

Ding LN, Yoshida T, Isobe K, Rahman SM, Nagase F, Yokochi T, Kawashima K, Nakashima I. Characterization of the individual and cross-reactive antigens involved in the anti-tumor immunity induced by use of an H-2K-erbB recombinant gene transfectant. Jpn. J. Cancer Res. 1991 Jul; 82(7): 841-7. PMID: 1679057, ISSN: 0910-5050.

Zhang YH, Yoshida T, Isobe K, Rahman SM, Nagase F, Ding L, Nakashima I. Modulation by glycyrrhizin of the cell-surface expression of H-2 class I antigens on murine tumour cell lines and normal cell populations. Immunology. 1990 Jul; 70(3): 405-10. PMID: 1696243, PMCID: PMC1384173, ISSN: 0019-2805.

Rahman SM, Kawashima K, Nakashima I, Nagase F. Induction of high-grade tumor-specific immunity in a host using a cytotoxic T-lymphocyte clone specific for a stable tumor antigen on murine leukemia L1210. Cancer Res. 1988 Nov 11/15/1988; 48(22): 6450-4. PMID: 3263189, ISSN: 0008-5472.

Mizoguchi K, Isobe K, Yoshida T, Iwamoto T, Hasegawa T, Ding L, Rahman SM, Miyata T, Nagase F, Shimokata K. Further evidence for H-2-unrestricted induction of minor histocompatibility antigens-specific T cell immunity in vivo. Immunol. Lett. 1988 Sep; 19(1): 41-7. PMID: 3263947, ISSN: 0165-2478.

Nagase F, Rahman SM, Yokochi T, Kawashima K, Isobe K, Yoshida T, Nagura E, Nakashima I. Dynamics of generation of antigen loss variants from L1210 murine leukemia clones detected by a tumor-specific T-cell clone. Cancer Res. 1987 Dec 12/15/1987; 47(24 Pt 1): 6494-9. PMID: 3499976, ISSN: 0008-5472.

Nagase F, Ueda K, Kawashima K, Jamshedur Rahman SM, Isobe K, Yoshida T, Hasegawa Y, Ando K, Iwamoto T, Nagura E. Development of host-dependent high-grade tumor-specific immunity through a novel mechanism triggered by the Lyt-2+ tumor-specific T cell clone (K7L) that induces temporal growth of L1210 leukemia-K7L-variant. J. Immunol. 1987 Apr 4/1/1987; 138(7): 2359-65. PMID: 2951438, ISSN: 0022-1767.